Cantel Medical and OsteoSymbionics Announce FDA 510(k) Clearance of ClearShield™ Implant Using Novel REVOX® Sterilization Process

Corporate Breaking News

Home : Cantel Medical and OsteoSymbionics Announce FDA 510(k) Clearance of ClearShield™ Implant Using Novel REVOX® Sterilization Process

May 28 2014	Cantel Medical and OsteoSymbionics Announce FDA 510(k) Clearance of ClearShield™ Implant Using Novel REVOX® Sterilization Process
LITTLE FALLS, N.J. and CLEVELAND, May 28, 2014 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) and OsteoSymbionics, a leading designer and manufacturer of innovative, patient-specific craniofacial implants, are pleased to announce FDA (U.S. Food and Drug Administration) 510(k)...


Source:http://www.prnewswire.com/news-releases/cantel-medical-and-osteosymbionics-announce-fda-510k-clearance-of-clearshield-implant-using-novel-revox-sterilization-process-260960291.html

Related News
» BlueStrata Announces Win at Missouri Veterans Commission » TechAmerica Foundation Names Congressman Michael McCaul House Legislator of the Year